基于人群的验证:美国国家综合癌症网络指南对皮肤黑色素瘤基线影像检查的建议
研究利用SEER数据库(2010-2015)109971例皮肤黑色素瘤患者,评估NCCN指南推荐的基线影像分期对肺、脑、骨、肝转移的检出性能。若所有III期患者均行常规影像,肺转移PPV为2.9%、NNI为34,骨和肝转移PPV均为1.8%、NNI均为55;排除临床淋巴结阴性/前哨淋巴结阳性患者可提高PPV并降低NNI。遵循NCCN指南对无症状肺、肝、脑、骨转移的漏检率低。
要点
- III期患者常规影像检出肺转移的PPV仅2.9%,每检出1例需检查34例。
- III期患者检出骨或肝转移的PPV均为1.8%,每检出1例均需检查55例。
- 排除临床淋巴结阴性/前哨淋巴结阳性患者可提高PPV并降低NNI。
核心结论
- 遵循当前NCCN指南对皮肤黑色素瘤进行基线影像分期,无症状肺、肝、脑或骨转移的漏检率低。
研究设计与样本
- 基于SEER数据库(2010-2015)的人群验证研究,纳入109971例皮肤黑色素瘤且TNM分期和远处转移部位信息完整的患者,评估NCCN指南推荐的基线影像检查对肺、脑、骨、肝转移的检出性能。
诊断标准与关键数值
- 若所有III期患者均行常规影像,识别肺转移的PPV为2.9%,检出1例肺转移的NNI为34。
- 若所有III期患者均行常规影像,识别骨转移的PPV为1.8%,检出1例骨转移的NNI为55。
- 若所有III期患者均行常规影像,识别肝转移的PPV为1.8%,检出1例肝转移的NNI为55。
- 排除临床淋巴结阴性/前哨淋巴结阳性疾病的III期患者可提高三个转移部位的PPV并降低NNI。
临床应用与阅片要点
- 遵循NCCN指南对皮肤黑色素瘤进行基线影像分期,无症状肺、肝、脑或骨转移的漏检率低。
- 排除临床淋巴结阴性/前哨淋巴结阳性患者后,三个转移部位的PPV提高、NNI降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The aim of the current study is to assess the performance of some of the imaging scans recommended in the National Comprehensive Cancer Network Guidelines as part of baseline staging for cutaneous melanoma, regarding the detection of lung, brain, bone, and liver metastases. Surveillance, Epidemiology and End Results database (2010-2015) was used to extract the data, and cases with cutaneous melanoma and complete information about TN stages and sites of distant metastases were explored. Performance parameters assessed in the current study included positive predictive value (PPV), negative predictive value, sensitivity, specificity, number needed to investigate (NNI), and accuracy. A total of 109 971 patients were included in the analysis. If all stage III patients in the study cohort are to be staged through routine imaging, PPV (for the recognition of lung metastases) will be 2.9% and NNI to detect one case of lung metastasis will be 34. Likewise, PPV (for the recognition of bone metastases) will be 1.8% and NNI to detect one case of bone metastasis will be 55. Moreover, PPV (for the recognition of liver metastases) will be 1.8% and NNI to detect one case of liver metastasis will be 55. Excluding stage III patients with clinically node-negative/sentinel node-positive disease would improve PPV and decrease NNI for the three metastatic sites. Adherence to current National Comprehensive Cancer Network guidelines for cutaneous melanoma imaging for baseline staging results in low rates of failure to detect asymptomatic lung, liver, brain, or bone metastases.
引用
- Abdel-Rahman O. Population-based validation of the National Cancer Comprehensive Network recommendations for baseline imaging workup of cutaneous melanoma. Melanoma Res. 2019. PMID: 30362976. doi:10.1097/CMR.0000000000000528
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。